tofacitinib solution
NDC 0054-0821, tofacitinib, solution, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0054-0821
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216878
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0821 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE1 mg/mL
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0054-0821-58 | 00054082158 | 1 BOTTLE in 1 CARTON (0054-0821-58) / 240 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d9cf18a9-e825-49ac-b080-68957c0e79ae
Use it
Look up 0054-0821 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0821 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0054-0821. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.